Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients

Diabetes
L CominaciniE Ferrannini

Abstract

Troglitazone, an oral antidiabetic agent with antioxidant properties, has previously been shown to increase the resistance of LDL to oxidation in vitro and in vivo in healthy volunteers. In a randomized, placebo-controlled, parallel-group study in 29 patients with NIDDM, we tested the effect of troglitazone (200 mg once daily) on the resistance of LDL to oxidation and on circulating levels of preformed lipid hydroperoxides and the adhesion molecule E-selectin. Resistance of LDL to oxidation was assessed by measuring 1) fluorescence development induced by copper treatment (lag phase), and 2) amount of thiobarbituric acid-reactive substances (TBARS) generated by incubation with umbilical vein endothelial cells. At 8 weeks, the lag phase was increased by 23% (P < 0.01 by analysis of covariance [ANCOVA]) in the patients receiving troglitazone (n = 18) compared with the group receiving placebo (n = 11). At the same time, TBARS were 3.63 +/- 0.10 nmol/l (vs. 5.32 +/- 0.10 nmol/l in the placebo group, P = 0.009), LDL hydroperoxide concentration was reduced from 1.48 +/- 0.03 to 1.19 +/- 0.03 ng/mg (no change in the placebo group, P < 0.01), and plasma E-selectin levels decreased from 56.5 +/- 2.33 to 43.7 +/- 1.77 microg/l (no change ...Continue Reading

Citations

Oct 16, 2002·Current Cardiology Reports·Annaswamy Raji, Jorge Plutzky
Sep 12, 2000·Current Hypertension Reports·N Mikhail, M L Tuck
Jan 16, 2002·Current Hypertension Reports·Nikolaus Marx
Jul 27, 2001·Diabetes Technology & Therapeutics·M A Charles
Mar 7, 2001·Antioxidants & Redox Signaling·J M May, Z C Qu
Mar 30, 2005·International Anesthesiology Clinics·Achikam Grinberg, Kyung W Park
Oct 13, 2005·Journal of Cardiovascular Pharmacology·Grazyna SobalH Sinzinger
Aug 12, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Jennifer M KleinhenzC Michael Hart
Jun 21, 2001·Hypertension Research : Official Journal of the Japanese Society of Hypertension·A SugawaraS Ito
Aug 22, 2007·PPAR Research·Rachel E NisbetC Michael Hart
May 4, 2004·Journal of Diabetes and Its Complications·Paresh Dandona, Ahmad Aljada
Jun 17, 2005·Annales d'endocrinologie·J Girard
Apr 7, 2005·Current Medical Research and Opinion·B Staels
Jul 6, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Mohammad NewazAdebayo Oyekan
Jul 21, 2004·Endocrinology and Metabolism Clinics of North America·Daniel EinhornRobert R Henry
Aug 9, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Jeroen P H van WijkTon J Rabelink
Nov 24, 2005·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Daniel Walcher, Nikolaus Marx
Sep 21, 2006·Clinical Endocrinology·Wan Sub ShimBong Soo Cha
Mar 20, 1999·The Annals of Pharmacotherapy·E M Umland, A M Romanelli
Jul 3, 2002·Drugs·Fabrice M A C MartensTon J Rabelink
Dec 11, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·A Quiñones-GalvanE Ferrannini
Feb 13, 2001·Endocrine Reviews·J Calles-Escandon, M Cipolla
Aug 18, 2006·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Ramón Ríos-VázquezJuan Carlos Kaski
Feb 26, 2004·Drugs & Aging·Richard W Grant, James B Meigs
Mar 15, 2005·Journal of Endocrinological Investigation·S GianniniA Galli
May 31, 2019·International Journal of Molecular Sciences·Adriano Costa de CamargoAndrés R Schwember
Aug 30, 2000·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·K KawaiK I Nakamura
Aug 6, 2000·The Annals of Pharmacotherapy·M S Rendell, W R Kirchain
Feb 18, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Nikolaus MarxWolfgang Koenig
Sep 7, 2002·Circulation Research·Nikolaus Marx
Jul 18, 2006·The American Journal of Clinical Nutrition·Richard J DeckelbaumToru Seo
Jul 13, 1999·The Journal of Laboratory and Clinical Medicine·W A Oranje, B H Wolffenbuttel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.